e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Genetics and environmental factors underlying asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
R. Dandurand, T. Carroll, R. S. J. Estépar, J. Bourbeau, D. Eidelman (Montreal, Canada; Dublin, Ireland; Boston, United States Of America)
Source:
International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Session:
Genetics and environmental factors underlying asthma and COPD
Session type:
Poster Discussion
Number:
4780
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Dandurand, T. Carroll, R. S. J. Estépar, J. Bourbeau, D. Eidelman (Montreal, Canada; Dublin, Ireland; Boston, United States Of America). Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD. Eur Respir J 2014; 44: Suppl. 58, 4780
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept